摘要
脑胶质瘤是颅内最常见的原发性肿瘤,临床治疗的预后较差。诊疗一体化将诊断和治疗功能集成,随着纳米生物技术的兴起,诊疗一体化平台迅速发展,为脑胶质瘤的诊疗带来了更多的选择。该文就脑胶质瘤诊疗一体化的发展进行综述。
Glioma is the most common primary tumor of the intracranial brain,and the prognosis of clinical treatment is poor.Diagnosis and treatment integration integrates the functions of diagnosis and treatment,and with the rise of nanobiotechnology,the diagnosis and treatment integration platform has developed rapidly,which brings more choices for the diagnosis and treatment of glioma.This article reviews the development of integrative diagnosis and treatment of glioma.
作者
王胜
李勇刚
WANG Sheng;LI Yong-gang(Department of Radiology,First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,215006,China)
出处
《中国血液流变学杂志》
CAS
2021年第1期142-150,共9页
Chinese Journal of Hemorheology